The complete genome of West Nile (Sarafend) virus [WN(S)V] was sequenced. Phylogenetic trees utilizing the complete genomic sequence, capsid gene, envelope gene and NS5 gene/3′ untranslated region of WN(S)V classified WN(S)V as a lineage II virus. A full-length infectious clone of WN(S)V with a point mutation in the glycosylation site of the envelope protein (pWNS-S154A) was constructed. Both growth kinetics and the mode of maturation were affected by this mutation. The titre of the pWNS-S154A virus was lower than the wild-type virus. This defect was corrected by the expression of wild-type envelope protein in trans. The pWNS-S154A virus matured intracellularly instead of at the plasma membrane as shown for the parental WN(S)V.
BakonyiT.,
HubalekZ.,
RudolfI.,
NowotnyN.2005; Novel flavivirus or new lineage of West Nile virus, central Europe. Emerg Infect Dis 11:225–231[CrossRef]
BeasleyD. W.,
BarrettA. D.2002; Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J Virol 76:13097–13100[CrossRef]
BeasleyD. W.,
LiL.,
SudermanM. T.,
BarrettA. D.2002; Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 296:17–23[CrossRef]
BerthetF. X.,
ZellerH. G.,
DrouetM. T.,
RauzierJ.,
DigoutteJ. P.,
DeubelV.1997; Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses. J Gen Virol 78:2293–2297
BhuvanakanthamR.,
NgM. L.2005; Analysis of self-association of West Nile virus capsid protein and the crucial role played by Trp 69 in homodimerization. Biochem Biophys Res Commun 329:246–255[CrossRef]
ChambersT. J.,
HalevyM.,
NestorowiczA.,
RiceC. M.,
LustigS.1998; West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness. J Gen Virol 79:2375–2380
HalevyM.,
AkovY.,
Ben-NathanD.,
KobilerD.,
LachmiB.,
LustigS.1994; Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice. Arch Virol 137:355–370[CrossRef]
HaseT.1993; Virus-neuron interactions in the mouse brain infected with Japanese encephalitis virus. Virchows Arch B Cell Pathol Incl Mol Pathol 64:161–170[CrossRef]
HaseT.,
SummersP. L.,
EckelsK. H.,
BazeW. B.1987a; Maturation process of Japanese encephalitis virus in cultured mosquito cells in vivo and mouse brain cells in vivo
. Arch Virol 96:135–151[CrossRef]
HaseT.,
SummersP. L.,
EckelsK. H.,
BazeW. B.1987b; An electron and immunoelectron microscopic study of dengue-2 virus infection of cultured mosquito cells: maturation events. Arch Virol 92:273–291[CrossRef]
IshakH.,
TakegamiT.,
KamimuraK.,
FunadaH.2001; Comparative sequences of two type 1 dengue virus strains possessing different growth characteristics in vivo
. Microbiol Immunol 45:327–331[CrossRef]
JohnsonA. J.,
GuirakhooF.,
RoehrigJ. T.1994; The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology 203:241–249[CrossRef]
LadV. J.,
ShendeV. R.,
GuptaA. K.,
KoshyA. A.,
RoyA.2000; Effect of tunicamycin on expression of epitopes on Japanese encephalitis virus glycoprotein E in porcine kidney cells. Acta Virol 44:359–364
LanciottiR. S.,
EbelG. D.,
DeubelV.& 9 other authors2002; Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology 298:96–105[CrossRef]
LiJ.,
BhuvanakanthamR.,
HoweJ.,
NgM. L.2005a; Identifying the region influencing the cis -mode of maturation of West Nile (Sarafend) virus using chimeric infectious clones. Biochem Biophys Res Commun 334:714–720[CrossRef]
LiL.,
BarrettA. D.,
BeasleyD. W.2005b; Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains. Virology 335:99–105[CrossRef]
LobigsM.,
DalgarnoL.,
SchlesingerJ. J.,
WeirR. C.1987; Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain). Virology 161:474–478[CrossRef]
ModisY.,
OgataS.,
ClementsD.,
HarrisonS. C.2003; A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 100:6986–6991[CrossRef]
Navarro-SanchezE.,
AltmeyerR.,
AmaraA.,
SchwartzO.,
FieschiF.,
VirelizierJ. L.,
Arenzana-SeisdedosF.,
DespresP.2003; Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep 4:723–728[CrossRef]
OliphantT.,
EngleM.,
NybakkenG. E.& 11 other authors2005; Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med 11:522–530[CrossRef]
PletnevA. G.,
BrayM.,
LaiC. J.1993; Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice. J Virol 67:4956–4963
RahmanS.,
MatsumuraT.,
MasudaK.,
KanemuraK.,
FukunagaT.1998; Maturation site of dengue type 2 virus in cultured mosquito C6/36 cells and Vero cells. Kobe J Med Sci 44:65–79
ReyF. A.,
HeinzF. X.,
MandlC.,
KunzC.,
HarrisonS. C.1995; The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375:291–298[CrossRef]
RymanK. D.,
LedgerT. N.,
WeirR. C.,
SchlesingerJ. J.,
BarrettA. D.1997; Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes. J Gen Virol 78:1353–1356
SanchezM. D.,
PiersonT. C.,
McAllisterD.,
HannaS. L.,
PufferB. A.,
ValentineL. E.,
MurtadhaM. M.,
HoxieJ. A.,
DomsR. W.2005; Characterization of neutralizing antibodies to West Nile virus. Virology 336:70–82[CrossRef]
ScherretJ. H.,
PoidingerM.,
MackenzieJ. S.,
BroomA. K.,
DeubelV.,
LipkinW. I.,
BrieseT.,
GouldE. A.,
HallR. A.2001a; The relationships between West Nile and Kunjin viruses. Emerg Infect Dis 7:697–705[CrossRef]
ScherretJ. H.,
MackenzieJ. S.,
KhromykhA. A.,
HallR. A.2001b; Biological significance of glycosylation of the envelope protein of Kunjin virus. Ann N Y Acad Sci 951:361–363
ScherretJ. H.,
MackenzieJ. S.,
HallR. A.,
DeubelV.,
GouldE. A.2002; Phylogeny and molecular epidemiology of West Nile and Kunjin viruses. Curr Top Microbiol Immunol 267:373–390
SerafinoA.,
ValliM. B.,
AlessandriniA.,
PonzettoA.,
CarloniG.,
BertoliniL.1997; Ultrastructural observations of viral particles within hepatitis C virus-infected human B lymphoblastoid cell line. Res Virol 148:153–159[CrossRef]
ShiP. Y.,
TilgnerM.,
LoM. K.,
KentK. A.,
BernardK. A.2002; Infectious cDNA clone of the epidemic West Nile virus from New York City. J Virol 76:5847–5856[CrossRef]
ShiratoK.,
MiyoshiH.,
GotoA.,
AkoY.,
UekiT.,
KariwaH.,
TakashimaI.2004; Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus. J Gen Virol 85:3637–3645[CrossRef]
SreenivasanV.,
NgK. L.,
NgM. L.1993; Brefeldin A affects West Nile virus replication in Vero cells but not C6/36 cells. J Virol Methods 45:1–17[CrossRef]
VorndamV.,
MathewsJ. H.,
BarrettA. D.,
RoehrigJ. T.,
TrentD. W.1993; Molecular and biological characterization of a non-glycosylated isolate of St Louis encephalitis virus. J Gen Virol 74:2653–2660[CrossRef]
WangY.,
LobigsM.,
LeeE.,
MullbacherA.2003; CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol 77:13323–13334[CrossRef]
WhealyM. E.,
CardJ. P.,
MeadeR. P.,
RobbinsA. K.,
EnquistL. W.1991; Effect of brefeldin A on alphaherpesvirus membrane protein glycosylation and virus egress. J Virol 65:1066–1081
ZhangW.,
ChipmanP. R.,
CorverJ.& 7 other authors2003; Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol 10:907–912[CrossRef]